{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:01:29Z","timestamp":1790244089162,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004728","name":"Vellore Institute of Technology Deemed to be University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004728","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Microbe"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.microb.2026.100783","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:38:41Z","timestamp":1787848721000},"page":"100783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comparative assessment of strategic application of mono-and-cocktail phage therapy in combatting dual-species biofilm architecture: A new hope for medical device sanitization"],"prefix":"10.1016","volume":"12","author":[{"given":"Bershiyal","family":"Sugumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramya","family":"Juliet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rithviha","family":"Thirumurugan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oishi","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nissy A.","family":"Bovas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogeswaran","family":"Jagadeesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasanth","family":"Manohar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8350-1809","authenticated-orcid":false,"given":"Ramesh","family":"Nachimuthu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.microb.2026.100783_bib1","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.3390\/antibiotics11121731","article-title":"Polymicrobial infections and biofilms: clinical significance and eradication strategies","volume":"11","author":"Anju","year":"2022","journal-title":"Antibiotics"},{"issue":". 136","key":"10.1016\/j.microb.2026.100783_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/apm.12099","article-title":"The role of bacterial biofilms in chronic infections","volume":"121","author":"Bjarnsholt","year":"2013","journal-title":"APMIS"},{"issue":"5","key":"10.1016\/j.microb.2026.100783_bib3","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3390\/pathogens13050393","article-title":"Medical device-associated biofilm infections and multidrug-resistant pathogens","volume":"13","author":"Bouhrour","year":"2024","journal-title":"Pathogens"},{"issue":"3","key":"10.1016\/j.microb.2026.100783_bib4","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1007\/s42770-023-01028-9","article-title":"Incidence of biofilms among the multidrug-resistant Escherichia coli isolated from urinary tract infections in the Nilgiris district, South India","volume":"54","author":"Cardiliya","year":"2023","journal-title":"Braz. J. Microbiol."},{"issue":"6","key":"10.1016\/j.microb.2026.100783_bib5","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2217\/fmb.13.47","article-title":"Phage cocktails and the future of phage therapy","volume":"8","author":"Chan","year":"2013","journal-title":"Future Microbiol."},{"key":"10.1016\/j.microb.2026.100783_bib6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.trsl.2020.03.010","article-title":"Topical application of bacteriophages for treatment of wound infections","volume":"220","author":"Chang","year":"2020","journal-title":"Transl. Res."},{"issue":"1","key":"10.1016\/j.microb.2026.100783_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12941-020-00389-5","article-title":"Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review","volume":"19","author":"Chegini","year":"2020","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"issue":"1","key":"10.1016\/j.microb.2026.100783_bib8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12941-021-00433-y","article-title":"Bacteriophage therapy for inhibition of multidrug-resistant uropathogenic bacteria: A narrative review","volume":"20","author":"Chegini","year":"2021","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"issue":"1","key":"10.1016\/j.microb.2026.100783_bib9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00430-025-00844-0","article-title":"Fighting biofilm: bacteriophages eliminate biofilm formed by multidrug-resistant Enterobacter hormaechei on urological catheters","volume":"214","author":"Cie\u015blik","year":"2025","journal-title":"Med. Microbiol. Immunol."},{"issue":"1","key":"10.1016\/j.microb.2026.100783_bib10","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1186\/s12879-021-06307-0","article-title":"Antibiotic susceptibility of human-associated Staphylococcus aureus and its relation to agr typing, virulence genes, and biofilm formation","volume":"21","author":"Derakhshan","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.microb.2026.100783_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.987011","article-title":"Editorial: Biofilm-mediated nosocomial infections and its association with antimicrobial resistance: detection, prevention, and management","volume":"9","author":"Devanga Ragupathi","year":"2022","journal-title":"Front. Med."},{"issue":"2","key":"10.1016\/j.microb.2026.100783_bib12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1128\/CMR.15.2.167-193.2002","article-title":"Biofilms: survival mechanisms of clinically relevant microorganisms","volume":"15","author":"Donlan","year":"2002","journal-title":"Clin. Microbiol. Rev."},{"issue":"9","key":"10.1016\/j.microb.2026.100783_bib13","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrmicro2415","article-title":"The biofilm matrix","volume":"8","author":"Flemming","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"issue":"12","key":"10.1016\/j.microb.2026.100783_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189621","article-title":"Clinical and economic impact of antibiotic resistance in developing countries: a systematic review and meta-analysis","volume":"12","author":"Founou","year":"2017","journal-title":"PLoS. One"},{"issue":"1","key":"10.1016\/j.microb.2026.100783_bib15","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1128\/AAC.00669-09","article-title":"Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system","volume":"54","author":"Fu","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.microb.2026.100783_bib16","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.2147\/IDR.S332051","article-title":"Acinetobacter baumannii biofilm formation and its role in disease pathogenesis: a review","volume":"14","author":"Gedefie","year":"2021","journal-title":"Infect. Drug. Resist."},{"issue":"3","key":"10.1016\/j.microb.2026.100783_bib17","doi-asserted-by":"crossref","DOI":"10.1186\/cc11357","article-title":"Implications of endotracheal tube biofilm in ventilator-associated pneumonia response: a state of concept","volume":"16","author":"Gil-Perotin","year":"2012","journal-title":"Crit. Care"},{"issue":"4","key":"10.1016\/j.microb.2026.100783_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2025.117061","article-title":"Antimicrobial resistance and biofilm formation in implants related infections: pathogens profiling and implants susceptibility","volume":"113","author":"Habib","year":"2025","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"7054","key":"10.1016\/j.microb.2026.100783_bib19","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/nature03912","article-title":"Aminoglycoside antibiotics induce bacterial biofilm formation","volume":"436","author":"Hoffman","year":"2005","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.microb.2026.100783_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00578-23","article-title":"Phage-antibiotic combinations against multidrug-resistant Pseudomonas aeruginosa in in vitro static and dynamic biofilm models","volume":"67","author":"Holger","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.microb.2026.100783_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-00457-w","article-title":"Insights into urinary catheter colonisation and polymicrobial biofilms of Candida-bacteria under flow condition","volume":"15","author":"Joshi","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.microb.2026.100783_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1391777","article-title":"Characterization of Salmonella phage of the genus Kayfunavirus isolated from sewage infecting clinical strains of Salmonella enterica","volume":"15","author":"Juliet","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.microb.2026.100783_bib23","article-title":"Phage cocktails: state-of-the-art technologies and strategies for effective design","volume":"50","author":"Kaneko","year":"2025","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.microb.2026.100783_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1588472","article-title":"Phage (cocktail)-antibiotic synergism: a new frontier in addressing Klebsiella pneumoniae resistance","volume":"16","author":"Karthika","year":"2025","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.microb.2026.100783_bib25","doi-asserted-by":"crossref","first-page":"9987","DOI":"10.1038\/s41467-024-53994-9","article-title":"A blueprint for broadly effective bacteriophage-antibiotic cocktails against bacterial infections","volume":"15","author":"Kim","year":"2024","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.microb.2026.100783_bib26","doi-asserted-by":"crossref","DOI":"10.1172\/JCI187996","article-title":"Bacteriophage therapy for multidrug-resistant infections: current technologies and therapeutic approaches","volume":"135","author":"Kim","year":"2025","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.microb.2026.100783_bib27","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev.micro.112408.134306","article-title":"Persister cells","volume":"64","author":"Lewis","year":"2010","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.microb.2026.100783_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1356179","article-title":"Phage-antibiotic combinations in various treatment modalities to manage MRSA infections","volume":"15","author":"Loganathan","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"18","key":"10.1016\/j.microb.2026.100783_bib29","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJMoa1801550","article-title":"Changes in prevalence of health care-associated infections in U.S. hospitals","volume":"379","author":"Magill","year":"2018","journal-title":"New. Engl. J. Med."},{"key":"10.1016\/j.microb.2026.100783_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1344962","article-title":"vitro and in vivo evaluation of the biofilm-degrading Pseudomonas phage Motto as a candidate for phage therapy","volume":"15","author":"Manohar","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.microb.2026.100783_bib31","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3389\/fmicb.2019.00574","article-title":"Therapeutic characterization and efficacy of bacteriophage cocktails infecting Escherichia coli, Klebsiella pneumoniae, and Enterobacter species","volume":"10","author":"Manohar","year":"2019","journal-title":"Front. Microbiol."},{"issue":"10","key":"10.1016\/j.microb.2026.100783_bib32","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3390\/pathogens14101011","article-title":"Phage to ESKAPE: personalizing therapy for MDR infections\u2014A comprehensive clinical review","volume":"14","author":"Marino","year":"2025","journal-title":"Pathogens"},{"issue":"7","key":"10.1016\/j.microb.2026.100783_bib33","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3390\/antibiotics13070623","article-title":"Medical device-associated infections caused by biofilm-forming microbial pathogens and controlling strategies","volume":"13","author":"Mishra","year":"2024","journal-title":"Antibiotics"},{"issue":"3","key":"10.1016\/j.microb.2026.100783_bib34","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3390\/pathogens15030288","article-title":"Antimicrobial resistance: a bibliometric review of patient health, mechanisms, and therapeutic strategies","volume":"15","author":"Murray","year":"2026","journal-title":"Pathogens"},{"issue":"2","key":"10.1016\/j.microb.2026.100783_bib35","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3390\/microorganisms11020424","article-title":"Phage-derived depolymerase: its possible role for secondary bacterial infections in COVID-19 patients","volume":"11","author":"Nazir","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.microb.2026.100783_bib36","article-title":"Lytic bacteriophages as alternative to overcoming antibiotic-resistant biofilms formed by clinically significant bacteria","volume":"12","author":"Osman","year":"2025","journal-title":"Ther. Adv. Infect. Dis."},{"issue":"17","key":"10.1016\/j.microb.2026.100783_bib37","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.3390\/ijms26178699","article-title":"Bacteriophage-based approach against biofilm infections associated with medical devices: a narrative review of ESKAPE pathogens","volume":"26","author":"Paw\u0142uszkiewicz","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.microb.2026.100783_bib38","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.3389\/fmicb.2020.02109","article-title":"Secondary effects of antibiotics on microbial biofilms","volume":"11","author":"Penesyan","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.microb.2026.100783_bib39","unstructured":"Performance standards for antimicrobial susceptibility testing,\u00a02025.\u00a0CLSI supplement M100,\u00a035th ed.\u00a0Clinical and Laboratory Standards Institute."},{"issue":"1","key":"10.1016\/j.microb.2026.100783_bib40","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4331\/wjbc.v8.i1.95","article-title":"Device-associated infection rates, mortality, length of stay and bacterial resistance in intensive care units in Ecuador: international nosocomial infection control consortium's findings","volume":"8","author":"Salgado Yepez","year":"2017","journal-title":"World J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.microb.2026.100783_bib41","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023080","article-title":"Bacteriophages combined with subtherapeutic doses of flucloxacillin act synergistically against Staphylococcus aureus experimental infective endocarditis","volume":"11","author":"Save","year":"2022","journal-title":"J. Am. Heart Assoc."},{"issue":"3","key":"10.1016\/j.microb.2026.100783_bib42","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3390\/v15030803","article-title":"Design of phage-cocktail-containing hydrogel for the treatment of Pseudomonas aeruginosa-infected wounds","volume":"15","author":"Shafigh Kheljan","year":"2023","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.microb.2026.100783_bib43","doi-asserted-by":"crossref","first-page":"28992","DOI":"10.1038\/s41598-024-79924-9","article-title":"Phage cocktail amikacin combination as a potential therapy for bacteremia associated with carbapenemase producing colistin resistant Klebsiella pneumoniae","volume":"14","author":"Shein","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.microb.2026.100783_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-12366-z","article-title":"Isolation and identification of bacteriophage against Escherichia coli ATCC 25922 and their biofilm inhibition studies","volume":"15","author":"Sivakumar","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.microb.2026.100783_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1292618","article-title":"A mechanism-based pathway toward administering highly active N-phage cocktails","volume":"14","author":"Smith","year":"2023","journal-title":"Front. Microbiol."},{"issue":"3","key":"10.1016\/j.microb.2026.100783_bib46","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nrmicro1838","article-title":"Physiological heterogeneity in biofilms","volume":"6","author":"Stewart","year":"2008","journal-title":"Nat. Rev. Microbiol."},{"issue":"18","key":"10.1016\/j.microb.2026.100783_bib47","doi-asserted-by":"crossref","first-page":"9193","DOI":"10.3390\/ijms26189193","article-title":"Catheter-associated urinary tract infections: understanding the interplay between bacterial biofilm and antimicrobial resistance","volume":"26","author":"Tegegne","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"22","key":"10.1016\/j.microb.2026.100783_bib48","doi-asserted-by":"crossref","first-page":"8671","DOI":"10.3390\/ijms21228671","article-title":"Pseudomonas aeruginosa biofilms","volume":"21","author":"Thi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.microb.2026.100783_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioflm.2020.100038","article-title":"CAUTI's next top model \u2013 model dependent Klebsiella biofilm inhibition by bacteriophages and antimicrobials","volume":"2","author":"Townsend","year":"2020","journal-title":"Biofilm"},{"key":"10.1016\/j.microb.2026.100783_bib50","series-title":"WHO bacterial priority pathogens list, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance","author":"World Health Organization","year":"2024"},{"issue":"1","key":"10.1016\/j.microb.2026.100783_bib51","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01258-23","article-title":"Designing phage cocktails to combat the emergence of bacteriophage-resistant mutants in multidrug-resistant Klebsiella pneumoniae","volume":"12","author":"Yoo","year":"2024","journal-title":"Microbiol. Spectr."},{"issue":"1","key":"10.1016\/j.microb.2026.100783_bib52","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s41538-025-00581-x","article-title":"The dual-species biofilm formed by Staphylococcus aureus and Pseudomonas fluorescens exhibited enhanced resistance to disinfectants","volume":"9","author":"Yuan","year":"2025","journal-title":"npj Sci. Food"},{"issue":"9","key":"10.1016\/j.microb.2026.100783_bib53","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.00607-24","article-title":"Antibacterial effect of phage cocktails and phage-antibiotic synergy against pathogenic Klebsiella pneumoniae","volume":"9","author":"Zhao","year":"2024","journal-title":"mSystems"},{"issue":"1","key":"10.1016\/j.microb.2026.100783_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-42505-3","article-title":"Bacteriophages with depolymerase activity in the control of antibiotic resistant Klebsiella pneumoniae biofilms","volume":"13","author":"Zurabov","year":"2023","journal-title":"Sci. Rep."}],"container-title":["The Microbe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950194626001299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950194626001299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:02:40Z","timestamp":1790240560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950194626001299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":54,"alternative-id":["S2950194626001299"],"URL":"https:\/\/doi.org\/10.1016\/j.microb.2026.100783","relation":{},"ISSN":["2950-1946"],"issn-type":[{"value":"2950-1946","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative assessment of strategic application of mono-and-cocktail phage therapy in combatting dual-species biofilm architecture: A new hope for medical device sanitization","name":"articletitle","label":"Article Title"},{"value":"The Microbe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.microb.2026.100783","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100783"}}